Evaluation of molecular markers in a rat model of mammary carcinogenesis

Oncology Research

Volumn 17, Issue 10, 2009, Pages 483-493

  Vinothini, G ^a   Murugan, R Senthil ^a   Nagini, S ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Apoptosis; Breast cancer; Cell proliferation; Oxidative stress

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA ACTIN; CYCLINE; CYTOCHROME C; CYTOCHROME P450 1B1; DIMETHYLBENZ[A]ANTHRACENE; FAS LIGAND; GELATINASE B; GLUTATHIONE TRANSFERASE P1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR RELA; VASCULOTROPIN RECEPTOR 1; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; MESSENGER RNA; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST METASTASIS; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; ANIMAL; ENZYME IMMUNOASSAY; EVALUATION; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; METABOLISM; RAT; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 70349323438     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789735459     Document Type: Article

References (39)

1. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M. J. Cancer statistics. CA Cancer J. Clin. 58:71-96; 2007.
2. Yeole, B. B. Trends in cancer incidence in female breast, cervix uteri, corpus uteri and ovary in India. Asian Pac. J. Cancer Prev. 9:119-122; 2008.
3. Yager, J. D.; Davidson, N. E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354:270-282; 2006.
4. Darbre, P. D. Environmental oestrogens, cosmetics and breast cancer. Best Pract. Res. Clin. Endocrinol. Metab. 20:121-143; 2006.
5. Olea, N.; Olea-Seffano, M. F. Oestrogens and the environment. Eur. J. Cancer Prev. 5:491-496; 1995.
6. Jeffy, B. D.; Chirnomas, R. B.; Romagnolo, D. E. Epigenetics and breast cancer: Polycyclic aromatic hydrocarbons as risk factor. Environ. Mol. Mutagen 39:235-244; 2002.
7. Zheng, W.; Gustafson, D. R.; Sinha, R.; Cerhan, J. R.; Moore, D.; Hong, C. P.; Anderson, K. E.; Kushi, L. H.; Sellers, T. A.; Folsom, A. R. Well-done meat intake and the risk of breast cancer. J. Natl. Cancer Inst. 90:1724-1729; 1998.
8. Ruthann, A.; Rudel, M. S.; Kathleen, R.; Attfield, B. S.; Jessica, N.; Schifano, B. A.; Brondy, J. G. Chemicals causing mammary gland tumours in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer Suppl. 109:2635-2666; 2007.
9. Shan, L.; Yu, M.; Snyderwine, E. G. Global gene expresion profiling of chemically induced rat mammary gland carcinomas and adenomas. Toxicol. Pathol. 33:768-775; 2005.
10. Vinothini, G.; Vidjaya Letchoumy, P.; Prathiba, D.; Nagini, S. Immunohistochemical analysis of biomarkers in patients with adenocarcinoma of the breast: Correlation with menopausal status and histological grade. Arch. Med. Sci. 4:129-139; 2008.
11. Giancotti, V. Breast cancer marker. Cancer Lett. 243: 145-159; 2006.
12. Russo, J.; Russo, I. H. Experimentally induced mammary tumours in rats. Breast Cancer Res. Treat. 39:7-20; 1996.
13. Russo, J.; Gusterson, B. A.; Rogers, A. E.; Russo, I. H.; Wellings, S. R.; van Zwieten, M. J. Comparative study of human and rat mammary tumorigenesis. Lab. Invest. 62: 244-278; 1990.
14. Russo, J.; Russo, I. H. Atlas and histologic classification of tumours of the rat mammary gland. J. Mammary Gland Biol. Neoplasia 5:187-200; 2000.
15. Costa, I.; Solanas, M.; Escrich, E. Histopathologic characterization of mammary neoplastic lesions induced with 7,12-dimethyl benz(alpha)anthracene in the rat: A comparative analysis with human breast tumours. Arch. Pathol. Lab. Med. 126:915-927; 2002.
16. Malejka-Giganti, D.; Niehaks, G. A.; Reichert, M. A. Post-initiation treatment of rats with indole-3-carbinol or beta-naphthoflavone does not suppress 7,12-dimethylbenz [a]anthracene-induced mammary gland carcinogenesis. Cancer Lett. 160:209-218; 2000.
17. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159; 1987.
18. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254; 1976.
19. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685; 1970.
20. Tsuchiya, Y.; Nakajima, M.; Yokoi, T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 227:115-124; 2005.
21. Yang, X.; Solomon, S.; Fraser, L. R.; Trombino, A. F.; Liu, D.; Sonenshein, G. E.; Hestermann, E. V.; Sherr, D. H. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissues. J. Cell. Biochem. 104:402-417; 2008.
22. Gago-Dominguez, M.; Castelao, J. E.; Pike, M. C.; Sevanian, A.; Haile, R. W. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cancer Epidemiol. Biomarkers Prev, 14:2829-2839; 2005.
23. Kato, Y.; Mori, Y.; Makino, Y.; Morimitsu, Y.; Hiroi, S.; Ishikawa, T.; Osawa, T. Formation of N∈-(hexanonyl) lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J. Biol. Chem. 214:20406-20414; 1999.
24. Matsui, A.; Ikeda, T.; Enomoto, K.; Hosoda, K.; Nakashima, H.; Omae, K.; Watanabe, M.; Hibi, T.; Kitajima, M. Increased formation of oxidative DNA damage, 8-hydroxy-2?-deoxy-guanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 151:87-95; 2000.
25. Clerkin, J. S.; Naughton, C.; Quiney, C.; Cotter, T. G. Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett. 266:30-36; 2008.
26. Lacroix, M.; Toillon, R. A.; Leclercq, G. p53 and breast cancer, an update. Endocrine Related Cancer 13:293-325; 2006.
27. Kumaragumparan, R.; Seshagiri, P. B.; Hara, Y.; Nagini, S. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: Modulation of xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation, apoptosis and angiogenesis. Mol. Carcinog. 46:797-806; 2007.
28. Malkas, L. H.; Herbert, V.; Abdel-Aziz, W.; Dobrolecki, L. E.; Liu, V.; Agarwal, B.; Hoelz, D.; Badve, S.; Schnaper, L.; Arnold, R. J.; Mechref, Y.; Novotny, M. V.; Loehrer, P.; Goulet, R. J.; Hickey, R. J. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc. Natl. Acad. Sci. USA 103: 19472-19477; 2006.
29. Huang, J.; Tan, P. H.; Tan, B. K. H.; Bay, B. H. GST-Pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol. Rep. 12:921-925; 2004.
30. Biswas, D. K.; Cruz, A. P.; Gansberger, E.; Pardee, A. B. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc. Natl. Acad. Sci. USA 97:8542-8547; 2000.
31. Tamatani, M.; Che, Y. H.; Matsuzaki, H.; Ogawa, S.; Okado, H.; Miyake, S.; Mizuno, T.; Tohyama, M. Tumour necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274:8531-8538; 1999.
32. Taylor, R. C.; Cullen, S. P.; Martin, S. J. Apoptosis: Controlled demolition at the cellular level. Mol. Cell. Biol. 9: 231-241; 2008.
33. Krishnamachary, B.; Semenza, G. L. Analysis of hypoxia-inducible factor 1 alpha expression and its effects on invasion and metastasis. Methods Enzymol. 435:347-357; 2007.
34. Duffy, M. J. Urokinase plasminogen activator and its inhibitor PAI-1 as prognostic markers in breast cancer: From pilot to level 1 evidence studies. Clin. Chem. 48: 1194-1197; 2002.
35. Bartsch, J. E.; Staren, E. D.; Appert, H. E. Matrix metalloproteinase expression in breast cancer. J. Surg. Res. 110: 383-392; 2003.
36. Span, P. N.; Sweep, C. G.; Manders, P.; Beex, L. V.; Leppert, D.; Lindberg, R. L. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: A prognostic marker for good clinical outcome in human breast carcinoma. Cancer 97:2710-2715; 2003.
37. Noda, M.; Takahashi, C. Recklessness as a hallmark of aggressive cancer. Cancer Sci. 98:1659-1665; 2007.
38. Hyder, S. M. Sex-steroids regulation of vascular endothelial growth factor in breast cancer. Endocr. Relat. Cancer 13:667-678; 2006.
39. Wu, Y.; Hooper,, A. T.; Zhong, Z.; Witte, L.; Bohlen, P.; Rafii, S.; Hicklin, D. J. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Int. J. Cancer 119:1519-1529; 2006.